Mesenchymal stromal cells (MSCs) are instrumental for MM progression and chemoresistance, and NF-κB is reported to be activated in vitro by feed-forward signals from both myeloma and other BM-dwelling cell types [12, 13]. Here, NFKB1 is linked to Miyoshi myopathy.